4 (428)

^3    i poiMofc*, .    ^,U

^J*. ^-rV- i

fc- WcU^ uWa.w

jj” p

£ _ ^'^V'^V'™VC&J«_ ^W^5<-W&v«

'U

LvZ~ ^ m—^

»«^ ©f ** H°v*i.

⁶' "“t. o© ‘~*>'^l~r

^ ©hp>Wa . "*    ^ ^U'

**65    , '    '

^~~ ^    3 CMhrA" u    o

■ ^wcer ©ad r. De,_bt

t - VA,

?W' O.wft-OL' VA O^Ł- ,    2 ~2o

/U0<itK'0(jO^ ‘-'lOjdA

“Z-O-A^ VL-'^V

(cx>)/vtxDod w pn-tzAi &p(A C^i-c^ta^ ^^isid-e^AA-Ł    d£J©cA/Y^vv -

m

/1.A6C /A 13

^J^©,_6s,_e

ęi -p

l°*^cvaXo „    - , ,

*>oJ . r ^

^£ - £ IT ^Ł

^ \^c:xavuvvv_V _    r

. ^,;h^-.? t*,₀    *-v^

^ŁJ    „

Q ^Vove "J- 4-^vevd\t© daW^ca^ujp© lA/d^w^-Lao.

h (y^-UZ/A-lłA Ol cdi^WŁ^O jC© pi/\£UxdAAW<- ,

A* j£/A CuAopvieu^dc©«-^AA ₍ !oA<- łu/Ci/Du Lu>lM.p’cXv/Vv^ '\/Y\ft)UV\o?L&-jyi'<S\ri< 2 J^j &

^ ~ rkfc\cAvi WUA (5 ’J\^A\ ę_ ©JO v\jV\tf\avAo.^uAaaJu^a

_IćW^ Gn \ M ^y

C. ” C/UzyWiA^. A^XtAAA©^\<ij«VvYvj    l/u^M^6uu Jr\^

iwawuwo jUtOi/t.scet-ACj i

^ " (L/U^yYwA VUXAM&AoishtL\v''^/\ J l/UjLlAjuMi tYMt/kodl^ \(JoU)uC'VVv^ Z U//y(juo vwp kg. tu ©AA c/u^ęl©*. iooiwilua. opijaj. Mffw€^^a

Ctvv Wj ^ ©a £'*-"^N

Oidlo    IM/ IjoaMav£i>'»A'j i,^

,, [ V, J?ć>/    0    3 J

/l.MC&e Z. a 3 4D <4. A60 5\Ó£ć-

©o C-d/o. \AiAcV-<lAA^p tVj CA^j (JU

rlw-G.

dcJd c/dj^vv

A - cb^U>P\t- <-A'^V^vd^J ok_oodr\<x^'J^ >-5 ^©^ '-UŁko-iJ^

/Y\s^lc. ' itb^l

Q) - o>\co ^90-07 ^    |9 ^,--^9 ^    ^ -j ^ vcxa 2- yupO-v/

t©

(- ~~ Z'~^>^Q-p 'A \'GAj^vQ_ vO HCMaAj^Cl u© WlA ^ lt_lc_v C©\

^ ~    OV>AGU.</jiiro\^    vd^S>^C^

t ' pa^cJL/ui^^

_r,3/^>.f_hę>.^ ^ rć'^f

GlaxoSmithKline